CDCA4 and triple-negative breast carcinoma: For instance, Pang S et al. revealed that CDCA4 probably participated in the modulation of human triple negative breast cancer (TNBC) progression and CDCA4 might be a newly produced target in TNBC treatment field (Pang et al., 2019).